AI Trading Robot Capitalizes on MACD Trend to Secure 4.47% Profit for $AMGN
Last week witnessed a strong performance from biotech firm Amgen (AMGN), with an artificial intelligence (AI)-based trading robot facilitating a 4.47% gain. This feat underlines the growing potential of AI in stock market trading. Specifically, the AI trading robot was able to leverage technical analysis, using the Moving Average Convergence Divergence (MACD) indicator, to exploit the inherent market opportunities.
For the uninitiated, the MACD is a trend-following momentum indicator that displays the relationship between two moving averages of a security's price. It involves subtracting the 26-period Exponential Moving Average (EMA) from the 12-period EMA. A nine-day EMA of the MACD, known as the "signal line," is then drawn on top of the MACD, which can function as a trigger for buy and sell signals.
In AMGN's case, the MACD turned positive on July 11, 2023, signaling a potential upward trend. This signal is considered bullish, indicating that it may be an optimal time to purchase shares. Historical analysis supports this: when AMGN's MACD turned positive in the past, the stock continued to rise in 27 out of 41 cases over the subsequent month, suggesting an upward trend continuation probability of 66%.
The AI trading robot capitalized on this signal, generating a profitable return of 4.47% over the course of the week. This was not a random outcome; rather, it demonstrates the efficacy of AI in discerning and acting upon complex market signals in real-time.
AI's success in this context lies in its ability to process vast amounts of data quickly and accurately, something that would take a human trader significantly more time. In addition to speed, AI can consistently apply trading rules without allowing emotions to interfere, a common pitfall for human traders.
In AMGN's case, the AI trading robot's strategy relied on the MACD's positive turn, an indicator that was substantiated by historical trends. It's a reminder that, while technical analysis cannot predict future price movements with 100% accuracy, it can provide valuable statistical insights into potential market behavior.
The AI trading robot's impressive 4.47% profit generation last week for AMGN illustrates the promising potential of AI in stock market trading. It serves as a testament to the potential synergy of technology and financial market, delivering significant returns based on reliable technical analysis tools like MACD. As the field of AI continues to evolve, we can expect an even greater precision and consistency in trading strategy execution, marking a new era of algorithmic trading.
AMGN in upward trend: 10-day moving average moved above 50-day moving average on June 05, 2025
The 10-day moving average for AMGN crossed bullishly above the 50-day moving average on June 05, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on May 22, 2025. You may want to consider a long position or call options on AMGN as a result. In of 73 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for AMGN just turned positive on May 16, 2025. Looking at past instances where AMGN's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .
AMGN moved above its 50-day moving average on May 30, 2025 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AMGN advanced for three days, in of 302 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 222 cases where AMGN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 16 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
AMGN broke above its upper Bollinger Band on May 30, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: AMGN's P/B Ratio (24.331) is slightly higher than the industry average of (5.632). P/E Ratio (22.661) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (2.526) is also within normal values, averaging (3.004). Dividend Yield (0.031) settles around the average of (0.161) among similar stocks. P/S Ratio (5.402) is also within normal values, averaging (3.643).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. AMGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of human therapeutic products based on cellular biology
Industry PharmaceuticalsMajor
Advertisement